This paper is in the following e-collection/theme issue:

Research Letter (86) Cyberpharmacies (48) Cost-Effectiveness and Economics (259) Pharmacology and Pharmaceutics (70) ePrescribing and Innovations in Pharmacies (56)

Published on in Vol 7 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/64300, first published .
Improving Affordability in Dermatology: Cost Savings in Mark Cuban Cost Plus Drug Company Versus GoodRx

Improving Affordability in Dermatology: Cost Savings in Mark Cuban Cost Plus Drug Company Versus GoodRx

Improving Affordability in Dermatology: Cost Savings in Mark Cuban Cost Plus Drug Company Versus GoodRx

Authors of this article:

Christopher G Youn1 Author Orcid Image ;   Joo Yeon Kim1 Author Orcid Image ;   Vivian B Yang2 Author Orcid Image ;   Gordon H Bae1 Author Orcid Image
Article Authors Cited by Tweetations Metrics

There are no citations yet available for this article according to Crossref .